SpringerLink
Log in

Intrinsic Wave Velocity Propagation: A Novel Parameter for Assessing the Effect of Anthracycline Chemotherapy Agents on Cardiac Diastolic Function in Breast Cancer Patients

  • Original Articles
  • Published:
Current Medical Science Aims and scope Submit manuscript

Abstract

Objective

Anthracycline chemotherapeutic agents have significant cardiotoxicity. The present study emphasized the effect of anthracycline chemotherapy drugs on left ventricular (LV) myocardial stiffness in breast cancer patients by measuring the intrinsic wave velocity propagation (IVP), and evaluating the potential clinical value of IVP in detecting early LV diastolic function impairment.

Methods

A total of 68 newly diagnosed breast cancer patients, who were treated with anthracycline-based chemotherapy, were analyzed. Transthoracic echocardiography was performed at baseline (T0), and after 1, 2, 3, 4 and 8 chemotherapeutic cycles (T1, T2, T3, T4 and T5, respectively). Then, the IVP, LV strain parameters [global longitudinal strain (GLS), longitudinal peak strain rate at systole (LSRs), longitudinal peak strain rate at early diastole (LSRe), longitudinal peak strain rate at late diastole (LSRa), and the E/LSRe ratio], and conventional echocardiographic parameters were obtained and further analyzed. A relative reduction of >15% in GLS was considered a marker of early LV subclinical dysfunction.

Results

Compared to the T0 stage, IVP significantly increased at the T1 stage. However, there were no significant changes in GLS, LSRs, or LSRe between the T0 and T1 stages. These parameters significantly decreased from the T2 stage. LSRa started to significantly decrease at the T5 stage, and the E/LSRe ratio started to significantly increase at the T3 stage (all P<0.05). At the T0 stage, IVP (AUC=0.752, P<0.001) had a good predictive value for LV subclinical dysfunction after chemotherapy.

Conclusions

IVP is a potentially sensitive parameter for the early clinical assessment of anthracycline-related cardiac diastolic impairment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol, 2022,95(1130):20211033

    Article  PubMed  Google Scholar 

  2. Berry GJ, Jorden M. Pathology of radiation and anthracycline cardiotoxicity. Pediatr Blood Cancer, 2005,44(7):630–637

    Article  PubMed  Google Scholar 

  3. Piegari E, De Angelis A, Cappetta D, et al. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. Basic Res Cardiol, 2013,108(2):334

    Article  PubMed  Google Scholar 

  4. Molinaro M, Ameri P, Marone G, et al. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs. Biomed Res Int, 2015,2015:138148

    Article  PubMed  PubMed Central  Google Scholar 

  5. McGowan JV, Chung R, Maulik A, et al. Anthracycline Chemotherapy and Cardiotoxicity. Cardiovasc Drugs Ther, 2017,31(1):63–75

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gulati M, Mulvagh SL. The connection between the breast and heart in a woman: Breast cancer and cardiovascular disease. Clin Cardiol, 2018,41(2):253–257

    Article  PubMed  PubMed Central  Google Scholar 

  7. Upshaw JN, Finkelman B, Hubbard RA, et al. Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy. JACC Cardiovasc Imaging, 2020,13(1 Pt 2):198–210

    Article  PubMed  Google Scholar 

  8. Lipshultz SE, Adams MJ, Colan SD, et al. Longterm cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation, 2013,128(17):1927–1995

    Article  PubMed  Google Scholar 

  9. Pfeffer MA, Shah AM, Borlaug BA. Heart Failure With Preserved Ejection Fraction In Perspective. Circ Res, 2019,124(11):1598–1617

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Pislaru C, Pellikka PA, Pislaru SV. Wave propagation of myocardial stretch: correlation with myocardial stiffness. Basic Res Cardiol, 2014,109(6):438

    Article  PubMed  PubMed Central  Google Scholar 

  11. Pislaru C, Alashry MM, Thaden JJ, et al. Intrinsic Wave Propagation of Myocardial Stretch, A New Tool to Evaluate Myocardial Stiffness: A Pilot Study in Patients with Aortic Stenosis and Mitral Regurgitation. J Am Soc Echocardiogr, 2017,30(11):1070–1080

    Article  PubMed  Google Scholar 

  12. Zhang J, Deng Y, Tang Q, et al. Evaluation of Myocardial Stiffness in Hypertensive Patients by Intrinsic Wave Propagation of the Myocardial Stretch. Ultrasound Med Biol, 2020,46(10):2683–2691

    Article  PubMed  Google Scholar 

  13. Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr, 2016,29(4):277–314

    Article  PubMed  Google Scholar 

  14. Celutkiene J, Pudil R, Lopez-Fernandez T, et al. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Eur J Heart Fail, 2020,22(9):1504–1524

    Article  CAS  PubMed  Google Scholar 

  15. Lyon AR, Lopez-Fernandez T, Couch LS, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J, 2022,43(41):4229–4361

    Article  PubMed  Google Scholar 

  16. Zamorano JL, Lancellotti P, Rodriguez Munoz D, et al. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). Eur Heart J, 2016,37(36):2768–2801

    Article  PubMed  Google Scholar 

  17. Cardinale D, Colombo A, Bacchiani G, et al. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation, 2015,131(22):1981–1988

    Article  CAS  PubMed  Google Scholar 

  18. Gulati G, Zhang KW, Scherrer-Crosbie M, et al. Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab. Curr Heart Fail Rep, 2014,11(4):366–373

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chan J, Shiino K, Obonyo NG, et al. Left Ventricular Global Strain Analysis by Two-Dimensional Speckle-Tracking Echocardiography: The Learning Curve. J Am Soc Echocardiogr, 2017,30(11):1081–1090

    Article  PubMed  Google Scholar 

  20. Charbonnel C, Convers-Domart R, Rigaudeau S, et al. Assessment of global longitudinal strain at low-dose anthracycline-based chemotherapy, for the prediction of subsequent cardiotoxicity. Eur Heart J Cardiovasc Imaging, 2017,18(4):392–401

    PubMed  Google Scholar 

  21. Timóteo AT, Moura Branco L, Filipe F, et al. Cardiotoxicity in breast cancer treatment: What about left ventricular diastolic function and left atrial function? Echocardiography, 2019,36(10):1806–1813

    Article  PubMed  Google Scholar 

  22. Sritharan HP, Delaney GP, Lo Q, et al. Evaluation of traditional and novel echocardiographic methods of cardiac diastolic dysfunction post radiotherapy in breast cancer. Int J Cardiol, 2017,243:204–208.

    Article  PubMed  Google Scholar 

  23. Li VW, Cheuk DK, Cheng FW, et al. Myocardial stiffness as assessed by diastolic wall strain in adult survivors of childhood leukaemias with preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging, 2017,18(4):451–458

    PubMed  Google Scholar 

  24. Villemain O, Correia M, Mousseaux E, et al. Myocardial Stiffness Evaluation Using Noninvasive Shear Wave Imaging in Healthy and Hypertrophic Cardiomyopathic Adults. JACC Cardiovasc Imaging, 2019,12(7 Pt 1):1135–1145

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ellims AH, Shaw JA, Stub D, et al. Diffuse myocardial fibrosis evaluated by post-contrast t1 map** correlates with left ventricular stiffness. J Am Coll Cardiol, 2014,63(11):1112–1118

    Article  PubMed  Google Scholar 

  26. Pislaru C, Ionescu F, Alashry M, et al. Myocardial Stiffness by Intrinsic Cardiac Elastography in Patients with Amyloidosis: Comparison with Chamber Stiffness and Global Longitudinal Strain. J Am Soc Echocardiogr, 2019,32(8):958–968.e4

    Article  PubMed  Google Scholar 

  27. De Jesus T, Alashry MM, Padang R, et al. Intrinsic cardiac elastography in patients with primary mitral regurgitation: predictive role after mitral valve repair. Eur Heart J Cardiovasc Imaging, 2021,22(8):912–921

    Article  PubMed  Google Scholar 

  28. Serrano JM, González I, Del Castillo S, et al. Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors. Oncologist, 2015,20(8):864–872

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China

    **ao Huang, **n-ying Fan, Qiao Cheng, Jun Zhang, Jie Sun, Qiao-ying Tang, You-bin Deng & **ao-jun Bi

Authors
  1. **ao Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. **n-ying Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiao Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qiao-ying Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. You-bin Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. **ao-jun Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to **ao-jun Bi.

Ethics declarations

The authors declare that there is no conflict of interest with any financial organization or corporation or individual that can inappropriately influence this work.

Additional information

The study was funded in part by the Hubei Province Health and Famliy Planning Scientific Research Project (No. WJ2023M011) and the Department of Finance of Hubei Province (No. 3890750).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huang, X., Fan, Xy., Cheng, Q. et al. Intrinsic Wave Velocity Propagation: A Novel Parameter for Assessing the Effect of Anthracycline Chemotherapy Agents on Cardiac Diastolic Function in Breast Cancer Patients. CURR MED SCI 43, 1229–1237 (2023). https://doi.org/10.1007/s11596-023-2807-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-023-2807-5

Key words

Search

Navigation